Advertisement

Plant Foods for Human Nutrition

, Volume 73, Issue 3, pp 235–240 | Cite as

t-Resveratrol Protects against Acute High Glucose Damage in Endothelial Cells

  • Leda Guzmán
  • Cristóbal Balada
  • Guillermo Flores
  • Rocío Álvarez
  • Marcela Knox
  • Raúl Vinet
  • José L. Martínez
Original Paper
  • 62 Downloads

Abstract

Postprandial hyperglycemia in diabetic and nondiabetic subjects is associated with endothelial dysfunction. Evidence shows that high glucose generates oxidative stress and a pro-inflammatory state promoting the development of cardiovascular diseases. trans-Resveratrol (t-RV) has been shown to reduce cardiovascular risk. To determine whether t-RV acts as a protector against acute high glucose (AHG)-induced damage, two in vitro models, rat aortic rings (RAR) and human umbilical vein endothelial cells (HUVEC) were used. RAR pretreated with AHG (25 mM D-glucose) for 3 h dramatically decreased the endothelium-dependent relaxation (EDR) induced by acetylcholine in phenylephrine (PE)-precontracted vessels. However, coincubation with t-RV significantly mitigated the damage induced by AHG on EDR. Pretreatment with AHG did not affect the vasodilation induced by sodium nitroprusside. HUVEC treated with t-RV decreased cytotoxicity and reduced radical oxygen species production induced by AHG. Taken together, these results suggest that t-RV can mitigate the AHG-induced EDR damage through a mechanism involving ROS scavenging and probably an increase in the bioavailability of NO.

Keywords

Postprandial hyperglycemia Acute high glucose Oxidative stress Rat aorta Human umbilical vein endothelial cells Resveratrol 

Abbreviations

ACh

Acetylcholine

AHG

Acute high glucose

EC50

The concentration of the compound that gives half-maximal response

EDR

Endothelium-dependent relaxation

Emax

Emax maximal effect (relaxation)

HUVEC

Human umbilical vein endothelial cells

KHB

Krebs-Henseleit buffer

MTS

3-(4,5-Dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium

NO

Nitric oxide

PE

Phenylephrine

RAR

Rat aortic rings

ROS

Reactive oxygen species

SNP

Sodium nitroprusside

t-RV

trans-Resveratrol

Notes

Acknowledgements

This work was supported by Grants DIUV No. 57/2011 from Universidad de Valparaíso, Chile; Grant CREAS No. R12C1001 from CONICYT-REGIONAL, GORE Región de Valparaíso, Chile; Grant No. 037-274 from Pontificia Universidad Católica de Valparaíso, Chile and Grant DICYT-USACH No. 021643MS from JLM.

Compliance with Ethical Standards

Conflicts of Interest

The authors state no conflict of interest.

References

  1. 1.
    O'Keefe JH, Bell DS (2007) Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100:899–904CrossRefGoogle Scholar
  2. 2.
    Fonseca V (2003) Clinical significance of targeting postprandial and fasting hyperglycemia in managing type 2 diabetes mellitus. Curr Med Res Opin 19:635–641CrossRefGoogle Scholar
  3. 3.
    Colette C, Monnier L (2007) Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes. Horm Metab Res 39:683–686CrossRefGoogle Scholar
  4. 4.
    Mah E, Noh SK, Ballard KD et al (2011) Postprandial hyperglycemia impairs vascular endothelial function in healthy men by inducing lipid peroxidation and increasing asymmetric dimethylarginine:arginine. J Nutr 141:1961–1968CrossRefGoogle Scholar
  5. 5.
    Loader J, Montero D, Lorenzen C, Watts R, Meziat C et al (2015) Acute hyperglycemia impairs vascular function in healthy and cardiometabolic diseased subjects: systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 35:2060–2072CrossRefGoogle Scholar
  6. 6.
    Vorn R, Yoo HY (2017) Effects of high glucose with or without other metabolic substrates on alpha-adrenergic contractions in rat mesenteric and femoral arteries. Korean J Physiol Pharmacol 21:91–97CrossRefGoogle Scholar
  7. 7.
    Tesfamariam B, Brown ML, Cohen RA (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87:1643–1648CrossRefGoogle Scholar
  8. 8.
    Tesfamariam B, Cohen RA (1992) Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol Heart Circ Physiol 263:H321–H326CrossRefGoogle Scholar
  9. 9.
    Tesfamariam B, Brown ML, Cohen RA (1992) Aldose reductase and myo-inositol in endothelial cell dysfunction caused by elevated glucose. J Pharmacol Exp Ther 263:153–157Google Scholar
  10. 10.
    Shuang-Xi W, Li-Ying L, Hu-Min Y-HL (2005) Na+/H+ exchanger inhibitor prevented endothelial dysfunction induced by high glucose. J Cardiovasc Pharmacol 45:586–590CrossRefGoogle Scholar
  11. 11.
    Goel A, Zhang Y, Anderson L, Rahimian R (2007) Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C beta and superoxide but not of Rho kinase. Cardiovasc Res 76:351–360CrossRefGoogle Scholar
  12. 12.
    Meng XH, Ni C, Zhu L et al (2009) Puerarin protects against high glucose-induced acute vascular dysfunction: role of heme oxygenase-1 in rat thoracic aorta. Vasc Pharmacol 50:110–115CrossRefGoogle Scholar
  13. 13.
    Vinet R, Martínez JL, Guzmán L (2015) The therapeutic potential of products based on polyphenols from wine grapes. In: Texeira-Duarte MC, Rai M (eds) Therapeutic medicinal plants: from lab to the market. CRC Press, New York, pp 331–342CrossRefGoogle Scholar
  14. 14.
    Giovinazzo G, Grieco F (2015) Functional properties of grape and wine polyphenols. Plant Foods Hum Nutr 70:454–462CrossRefGoogle Scholar
  15. 15.
    Khurana S, Venkataraman K, Hollingsworth A et al (2013) Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients 5:3779–3827CrossRefGoogle Scholar
  16. 16.
    Orallo F, Alvarez E, Camiña M et al (2002) The possible implication of trans-resveratrol in the cardioprotective effects of long-term moderate wine consumption. Mol Pharmacol 61:294–302CrossRefGoogle Scholar
  17. 17.
    Soylemez S, Gurdal H, Sepici A, Akar F (2008) The effect of long-term resveratrol treatment on relaxation to estrogen in aortae from male and female rats: role of nitric oxide and superoxide. Vasc Pharmacol 49:97–105CrossRefGoogle Scholar
  18. 18.
    Develi-Is S, Ozen G, Bekpinar S et al (2014) Resveratrol improves high-fructose-induced vascular dysfunction in rats. Can J Physiol Pharmacol 92:1021–1027CrossRefGoogle Scholar
  19. 19.
    Vinet R, Brieva C, Pinardi G, Penna M (1991) Influence of extracellular Ca2+ on the modulation of alpha-adrenergic-induced contractions in rat aorta. Gen Pharmacol 22:365–369CrossRefGoogle Scholar
  20. 20.
    Wu D, Yotnda P (2011) Production and detection of reactive oxygen species (ROS) in cancers. J Vis Exp 57:e3357Google Scholar
  21. 21.
    Monnier L, Lapinski H, Colette C (2003) Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 26:881–885CrossRefGoogle Scholar
  22. 22.
    Peter R, Dunseath G, Luzio SD, Chudleigh R, Choudhury SR, Owens DR (2009) Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with type 2 diabetes. Diabet Med 26:974–980CrossRefGoogle Scholar
  23. 23.
    Min Z, Kang L, Lin L et al (2010) Resveratrol restores lysophosphatidylcholine-induced loss of endothelium-dependent relaxation in rat aorta tissue coinciding with inhibition of extracellular-signal-regulated protein kinase activation. Phytother Res 24:1762–1768Google Scholar
  24. 24.
    Tang Y, Xu J, Qud W et al (2012) Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms. J Nutr Biochem 23:1410–1416CrossRefGoogle Scholar
  25. 25.
    Sena CM, Pereira AM, Seiça R (2013) Endothelial dysfunction - a major mediator of diabetic vascular disease. Biochim Biophys Acta 12:2216–2231CrossRefGoogle Scholar
  26. 26.
    Matsumoto T, Kakami M, Noguchi E et al (2007) Imbalance between endothelium-derived relaxing and contracting factors in mesenteric arteries from aged OLETF rats, a model of type 2 diabetes. Am J Physiol Heart Circ Physiol 293:H1480–H1490CrossRefGoogle Scholar
  27. 27.
    Mokhtar SS, Rasool AH (2015) Role of endothelium-dependent hyperpolarisation and prostacyclin in diabetes. Malays J Med Sci 22:8–17Google Scholar
  28. 28.
    Morrison KJ, Pollock D (1990) Impairment of relaxations to acetylcholine and nitric oxide by a phorbol ester in rat isolated aorta. Br J Pharmacol 101:432–436CrossRefGoogle Scholar
  29. 29.
    Gordish KL, Beierwaltes WH (2014) Resveratrol induces acute endothelium-dependent renal vasodilation mediated through nitric oxide and reactive oxygen species scavenging. Am J Physiol Ren Physiol 306:F542–F550CrossRefGoogle Scholar
  30. 30.
    Li T, Chen Y, Gua C, Li X (2017) Elevated circulating trimethylamine N-oxide levels contribute to endothelial dysfunction in aged rats through vascular inflammation and oxidative stress. Front Physiol 8:350CrossRefGoogle Scholar
  31. 31.
    Park SH, Jeong SO, Chung HT, Pae HO (2015) Pterostilbene, an active constituent of blueberries, stimulates nitric oxide production via activation of endothelial nitric oxide synthase in human umbilical vein endothelial cells. Plant Foods Hum Nutr 70:263–268CrossRefGoogle Scholar
  32. 32.
    Lee KW, Kang NJ, Rogozin EA et al (2008) The resveratrol analogue 3,5,3,4,5-pentahydroxy-trans-stilbene inhibits cell transformation via MEK. Int J Cancer 123:2487–2496CrossRefGoogle Scholar
  33. 33.
    Takizawa Y, Nakata R, Fukuhara K et al (2015) The 4′-hydroxyl group of resveratrol is functionally important for direct activation of PPARα. PLoS One 10:e0120865CrossRefGoogle Scholar
  34. 34.
    Trachootham D, Lu W, Ogasawara MA et al (2008) Redox regulation of cell survival. Antioxid Redox Signal 10:1343–1374CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Laboratory of Biological Chemistry, Institute of Chemistry, Faculty of SciencesPontificia Universidad Católica de ValparaísoValparaísoChile
  2. 2.Laboratory of Pharmacology, Faculty of PharmacyUniversidad de ValparaísoValparaísoChile
  3. 3.Centro de Investigación Farmacopea Chilena (CIFAR)ValparaísoChile
  4. 4.Regional Center for the Study in Foods and Health (CREAS)ValparaísoChile
  5. 5.Vice Presidency of Research, Development and InnovationUniversidad de Santiago de ChileSantiagoChile

Personalised recommendations